These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11504513)

  • 1. Recent pathology related advances in colorectal adenocarcinomas.
    Goldstein NS
    Eur J Surg Oncol; 2001 Aug; 27(5):446-50. PubMed ID: 11504513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological reporting of colorectal cancer specimens: a retrospective survey in an academic Canadian pathology department.
    Chan NG; Duggal A; Weir MM; Driman DK
    Can J Surg; 2008 Aug; 51(4):284-8. PubMed ID: 18815652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour budding in colorectal carcinoma.
    Prall F
    Histopathology; 2007 Jan; 50(1):151-62. PubMed ID: 17204028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality control of pathological examination in colorectal cancer].
    Teglbjaerg PS; Fenger C
    Ugeskr Laeger; 2005 Oct; 167(44):4170-2. PubMed ID: 16266570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of a proforma improves colorectal cancer pathology reporting.
    Rigby K; Brown SR; Lakin G; Balsitis M; Hosie KB
    Ann R Coll Surg Engl; 1999 Nov; 81(6):401-3. PubMed ID: 10655894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival.
    Baskaranathan S; Philips J; McCredden P; Solomon MJ
    Dis Colon Rectum; 2004 Dec; 47(12):2076-9. PubMed ID: 15657657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wedge resection margin distances and residual adenocarcinoma in lobectomy specimens.
    Goldstein NS; Ferkowicz M; Kestin L; Chmielewski GW; Welsh RJ
    Am J Clin Pathol; 2003 Nov; 120(5):720-4. PubMed ID: 14608898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical results of total pelvic exenteration for locally advanced colorectal adenocarcinoma.
    Takeuchi H; Ueo H; Haraoka M; Maehara Y
    Hepatogastroenterology; 2005; 52(61):90-3. PubMed ID: 15783002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
    Yano H; Saito Y; Kirihara Y; Takashima J
    Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability and survival rate in the solid or nonsolid types of poorly differentiated colorectal adenocarcinoma.
    Goi T; Hirono Y; Katayama K; Yamaguchi A
    Int Surg; 2004; 89(2):100-6. PubMed ID: 15285243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
    Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
    Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
    Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
    Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome.
    Hamady ZZ; Malik HZ; Alwan N; Wyatt JI; Prasad KR; Toogood GJ; Lodge JP
    Eur J Surg Oncol; 2008 Feb; 34(2):180-4. PubMed ID: 17983724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology reporting of resected colorectal cancers in New South Wales in 2000.
    Chapuis PH; Chan C; Lin BP; Armstrong K; Armstrong B; Spigelman AD; O'Connell D; Leong D; Dent OF
    ANZ J Surg; 2007 Nov; 77(11):963-9. PubMed ID: 17931258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of accurate pathological assessment of lymph node involvement in colorectal cancer.
    Schofield JB; Mounter NA; Mallett R; Haboubi NY
    Colorectal Dis; 2006 Jul; 8(6):460-70. PubMed ID: 16784464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular tumour clocks and colorectal cancer: seeing the unseen.
    Shibata D
    Pathology; 2002 Dec; 34(6):534-40. PubMed ID: 12555991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
    Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
    Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating colorectal polypoid neoplasms during a colonoscopy.
    Lin WP; Su MY; Ho YP; Hsu CM; Lin CJ; Chiu CT; Chen PC
    Chang Gung Med J; 2005 Nov; 28(11):801-7. PubMed ID: 16422187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
    Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
    Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.